Healthcare Outlook 2012 
Reenita Das, SVP Healthcare and Life Sciences, Frost & Sullivan

The Healthcare industry is undergoing a rapid transformation with a number of macro trends colliding together such as mobility, internet, consolidation, patient empowerment, global pandemics, aging population, evidence based medicine, prevention, medical tourism, etc. to create business model changes. These trends are altering the way Healthcare is implemented and delivered. This session will focus on the outlook for Asia Pacific with respect to these business model changes in pharmaceuticals, devices, diagnostics and Healthcare Information Technology and highlight growth opportunities for 2012 and beyond.

The Future of the Hospital in Asia
Rhenu Bhuller, VP Healthcare, Frost & Sullivan

As medicine becomes custom-tailored to fit individual needs, what role will a hospital play in the future? Currently the healthcare delivery sector in Asia is growing at alarming rates, with group purchasing organizations driving change. Healthcare corporations are developing ownership stake into hospitals, creating widespread transformation.

This session will cover an overview of the hospital landscape in Asia and the future growth opportunities for 2012 – snap shots into countries and markets will also be shared.

With over 20 years of experience in the healthcare marketing consulting business worldwide, Reenita has advised clients on marketing strategy, acquisitions, and new business ventures in all major industry segments. Reenita has worked very closely and provided market research consulting services to global companies such as Pfizer, Johnson & Johnson, IBM, GE among several others.
Reenita has been extensively quoted in the press and on TV, such as Wall Street Journal, CNBC, BBC and San Jose Mercury News. She speaks regularly at many conferences, delivering keynote speeches and leading think-tank sessions with senior executives of the Global Top 25 Healthcare companies.

Rhenu Bhuller has close to 20 years of healthcare industry knowledge, including 10 plus years of consulting expertise in the pharmaceutical and biotechnology sectors. She is an industry expert and has particular expertise in new market and therapeutic area analysis; sales, marketing and business planning; market entry and business strategy; strategy discussions with c-suites, government officials, etc. She is a regular keynote speaker at industry conferences and is also often in the media, featuring in BBC, Bloomberg, CNN and CNBC.

Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best-in-class positions in growth, innovation and leadership. The company’s Growth Partnership Service provides the CEO and the CEO’s Growth Team with disciplined research and best-practice models to drive the generation, evaluation, and implementation of powerful growth strategies. Frost & Sullivan leverages 50 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 40 offices on six continents. To join our Growth Partnership, please visit http://www.frost.com